MBX CIK: 1776111

MBX Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
83.5
FY24:
267
FY25:
382
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.72
FY24:
1.25
FY25:
3.61
Total assets
Change from FY23 to FY25
millions USD
FY23:
84.2
FY24:
269
FY25:
385

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
3.93
FY24:
11.1
FY25:
15.5
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.37
FY24:
0.04
FY25:
0.43
(positive)
Change from FY23 to FY25
millions USD
FY23:
−72.5
FY24:
257
FY25:
369
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
269
FY25:
385

All amounts in millions USD Data source:SEC EDGAR